Your browser doesn't support javascript.
loading
RELEASE: a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia.
Brady, Marian C; Ali, Myzoon; VandenBerg, Kathryn; Williams, Linda J; Williams, Louise R; Abo, Masahiro; Becker, Frank; Bowen, Audrey; Brandenburg, Caitlin; Breitenstein, Caterina; Bruehl, Stefanie; Copland, David A; Cranfill, Tamara B; Pietro-Bachmann, Marie di; Enderby, Pamela; Fillingham, Joanne; Galli, Federica Lucia; Gandolfi, Marialuisa; Glize, Bertrand; Godecke, Erin; Hawkins, Neil; Hilari, Katerina; Hinckley, Jacqueline; Horton, Simon; Howard, David; Jaecks, Petra; Jefferies, Elizabeth; Jesus, Luis M T; Kambanaros, Maria; Kang, Eun Kyoung; Khedr, Eman M; Kong, Anthony Pak-Hin; Kukkonen, Tarja; Laganaro, Marina; Ralph, Matthew A Lambon; Laska, Ann Charlotte; Leemann, Béatrice; Leff, Alexander P; Lima, Roxele R; Lorenz, Antje; MacWhinney, Brian; Marshall, Rebecca Shisler; Mattioli, Flavia; Mavis, Ilknur; Meinzer, Marcus; Nilipour, Reza; Noé, Enrique; Paik, Nam-Jong; Palmer, Rebecca; Papathanasiou, Ilias.
Afiliação
  • Brady MC; Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.
  • Ali M; Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.
  • VandenBerg K; Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.
  • Williams LJ; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Williams LR; Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.
  • Abo M; Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Becker F; University of Oslo, Oslo, and Sunnaas Rehabilitation Hospital, Bjørnemyr, Norway.
  • Bowen A; Division of Neuroscience & Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.
  • Brandenburg C; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
  • Breitenstein C; Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.
  • Bruehl S; School of Biological Sciences, University of Manchester, Manchester, UK.
  • Copland DA; School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
  • Cranfill TB; Special Education, Eastern Kentucky University, Richmond, KY, USA.
  • Pietro-Bachmann MD; Division of Neurorehabilitation, Department of Clinical Neurosciences, University Hospitals and University of Geneva, Geneva, Switzerland.
  • Enderby P; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Fillingham J; Nursing Directorate, NHS Improvement, London, UK.
  • Galli FL; Neurorehabilitation Clinic, Neurological Sciences Department, Marche Polytechnic University, Ancona, Italy.
  • Gandolfi M; Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Glize B; EA 4136 Handicap Activity Cognition Health, University of Bordeaux and Department of Physical Medicine and Rehabilitation, CHU de Bordeaux, France.
  • Godecke E; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
  • Hawkins N; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Hilari K; Division of Language and Communication Science, City, University of London, London, UK.
  • Hinckley J; Department of Speech-Language Pathology, Nova Southeastern University, Fort Lauderdale, FL, USA.
  • Horton S; School of Health Sciences, University of East Anglia, Norwich, UK.
  • Howard D; School of Education Communication and Language Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.
  • Jaecks P; Faculty of Linguistics and Literary Studies, Bielefeld University, Bielefeld, Germany.
  • Jefferies E; Department of Psychology, University of York, York, UK.
  • Jesus LMT; School of Health Sciences (ESSUA) and Institute of Electronics and Informatics Engineering of Aveiro (IEETA), University of Aveiro, Aveiro, Portugal.
  • Kambanaros M; Department of Rehabilitation Sciences, Cyprus University of Technology, Limassol, Cyprus.
  • Kang EK; Department of Rehabilitation Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
  • Khedr EM; Department of Neurology, Assiut University Hospital, Assiut, Egypt.
  • Kong AP; School of Communication Sciences and Disorders, University of Central Florida, Orlando, FL, USA.
  • Kukkonen T; ENT/Department of Phoniatry, Tampere University Hospital, Tampere, Finland.
  • Laganaro M; Faculty of Psychology and Educational Science, University of Geneva, Geneva, Switzerland.
  • Ralph MAL; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
  • Laska AC; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
  • Leemann B; Neurorééducation, Département des Neurosciences Cliniques, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Leff AP; Department of Brain Repair and Rehabilitation, Institute of Neurology, UCL, London, UK.
  • Lima RR; Department of Speech Language Pathology, Educational Association Bom Jesus - IELUSC, Santa Catarina, Brazil.
  • Lorenz A; Institut für Psychologie, Humboldt University Berlin, Berlin, Germany.
  • MacWhinney B; Department of Psychology, Carnegie Mellon University, Pittsburgh, PA, USA.
  • Marshall RS; Department of Communication Sciences and Special Education, University of Georgia, Georgia, USA.
  • Mattioli F; Neuropsychology Unit, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Mavis I; Department of Speech and Language Therapy, Anadolu University, Eskisehir, Turkey.
  • Meinzer M; UQ Centre for Clinical Research, The University of Queensland, Hertston, Australia.
  • Nilipour R; Department of Speech Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Noé E; NEURORHB-Hospitales Vithas, Valencia, Spain.
  • Paik NJ; Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Palmer R; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Papathanasiou I; Department of Speech and Language Therapy, Technological Educational Institute of Western Greece, Patras, Greece.
Aphasiology ; 34(2): 137-157, 2020 Feb.
Article em En | MEDLINE | ID: mdl-37560459
ABSTRACT

Background:

Speech and language therapy (SLT) benefits people with aphasia following stroke. Group level summary statistics from randomised controlled trials hinder exploration of highly complex SLT interventions and a clinically relevant heterogeneous population. Creating a database of individual participant data (IPD) for people with aphasia aims to allow exploration of individual and therapy-related predictors of recovery and prognosis.

Aim:

To explore the contribution that individual participant characteristics (including stroke and aphasia profiles) and SLT intervention components make to language recovery following stroke. Methods and procedures We will identify eligible IPD datasets (including randomised controlled trials, non-randomised comparison studies, observational studies and registries) and invite their contribution to the database. Where possible, we will use meta- and network meta-analysis to explore language performance after stroke and predictors of recovery as it relates to participants who had no SLT, historical SLT or SLT in the primary research study. We will also examine the components of effective SLT interventions. Outcomes and

results:

Outcomes include changes in measures of functional communication, overall severity of language impairment, auditory comprehension, spoken language (including naming), reading and writing from baseline. Data captured on assessment tools will be collated and transformed to a standardised measure for each of the outcome domains.

Conclusion:

Our planned systematic-review-based IPD meta- and network meta-analysis is a large scale, international, multidisciplinary and methodologically complex endeavour. It will enable hypotheses to be generated and tested to optimise and inform development of interventions for people with aphasia after stroke. Systematic review registration The protocol has been registered at the International Prospective Register of Systematic Reviews (PROSPERO; registration number CRD42018110947).
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article